rs7336610
Positions:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The ENST00000582141.6(MIR17HG):n.3326C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.472 in 151,662 control chromosomes in the GnomAD database, including 18,387 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.47 ( 18387 hom., cov: 29)
Consequence
MIR17HG
ENST00000582141.6 non_coding_transcript_exon
ENST00000582141.6 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.480
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 13-91352883-C-T is Benign according to our data. Variant chr13-91352883-C-T is described in ClinVar as [Benign]. Clinvar id is 3060743.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.577 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIR17HG | NR_027350.1 | n.3326C>T | non_coding_transcript_exon_variant | 2/2 | ||||
MIR17HG | NR_027349.1 | n.285-1050C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIR17HG | ENST00000582141.6 | n.3326C>T | non_coding_transcript_exon_variant | 2/2 | 1 | |||||
MIR17HG | ENST00000400282.7 | n.285-1050C>T | intron_variant | 1 | ||||||
MIR17HG | ENST00000710412.1 | n.1025C>T | non_coding_transcript_exon_variant | 3/3 |
Frequencies
GnomAD3 genomes AF: 0.472 AC: 71506AN: 151546Hom.: 18375 Cov.: 29
GnomAD3 genomes
AF:
AC:
71506
AN:
151546
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.472 AC: 71523AN: 151662Hom.: 18387 Cov.: 29 AF XY: 0.472 AC XY: 34937AN XY: 74086
GnomAD4 genome
AF:
AC:
71523
AN:
151662
Hom.:
Cov.:
29
AF XY:
AC XY:
34937
AN XY:
74086
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1721
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
MIR17HG-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 28, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at